Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial von Guglielmetti, L, Ardizzoni, E, Atger, M, Baudin, E, Berikova, E, Bonnet, M, Chang, E, Cloez, S, Coit, J. M, Cox, V, de Jong, B. C, Delifer, C, Do, J. M, Tozzi, D. Dos Santos, Ducher, V, Ferlazzo, G, Gouillou, M, Khan, A, Khan, U, Lachenal, N, LaHood, A. N, Lecca, L, Mazmanian, M, McIlleron, H, Moschioni, M, O'Brien, K, Okunbor, O, Oyewusi, L, Panda, S, Patil, S. B, Phillips, P. P. J, Pichon, L, Rupasinghe, P, Rich, M. L, Saluhuddin, N, Seung, K. J, Tamirat, M, Trippa, L, Cellamare, M, Velásquez, G. E, Wasserman, S, Zimetbaum, P. J, Varaine, F, Mitnick, C. D

Volltext